Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.
about
HIV-1 Vaccine Trials: Evolving Concepts and DesignsGranulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunityA push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40LMultispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization.Optimisation of DNA vaccines for the prophylaxis and modulation of herpes simplex virus infections.Strategies for designing and optimizing new generation vaccines.Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virusImpact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.Progress on new vaccine strategies against chronic viral infectionsRecent trends in vaccine delivery systems: A review.Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections.Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Problems and emerging approaches in HIV/AIDS vaccine development.A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protectionMucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virusTranscutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cellsHuman immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Strategies for optimizing targeting and delivery of mucosal HIV vaccines.Carbohydrate targets in HIV vaccine research: lessons from failures.Loss of growth factor sensitivity and development of mitoxantrone resistance in transplanted recurrent SA7HD myeloid leukemia.Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion.Differential T cell homing to colon vs. small intestine is imprinted by local CD11c+ APCs that determine homing receptors.Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells.Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
P2860
Q30425520-EF6D5EBB-B9D8-481C-9E69-0797DE0DC2CDQ33870105-3D395F6B-1ACA-446E-AD77-06ECFF424A47Q33946563-A155D68B-AB3B-4E68-A855-AEC6DC6A70FAQ34172564-2C8DA81B-737B-4C55-BE3E-831E99342222Q34191248-A454DA96-DC7D-48C2-B2E5-D593CE1ABA7EQ34226966-9ACC523A-EE20-4607-8F67-37A2F16E4E17Q34357220-7755BF2D-0725-46B8-95F5-0D26E522A52AQ34452049-8FB6D59B-74BD-48D3-A5A8-A9EE7952AB6EQ34572198-9ACCFBEF-0334-47F2-87D1-C7A60C282162Q35234767-A1452335-FAC3-4146-B6F8-402D08F80726Q35575565-F379E37E-091C-42AE-90DD-259E92B94DBCQ35705707-D59467B8-89FC-45F8-8A75-22D5D1985BAFQ35849596-4E1B2C5E-3072-4E9F-9EC7-EAADD0DA668DQ35864857-7AAAE638-9062-445A-8435-27C6DB39C30FQ36300181-FDE98B84-1E8A-486C-9ABD-60AFB4D02C09Q36320323-05FE41EE-D3C3-4A53-A5E9-78D39B421FD8Q36532471-308A48C6-4FFE-4F5D-B03A-FABFA00B576CQ36663607-1DF5EE91-CF5B-47E4-B390-275F3206B191Q36758574-0F5A83BC-D6BD-47E4-A6AF-38B0D65E8498Q36787928-3D5F3436-2A6C-4FF2-B369-21CAD8A4204BQ36943971-F3AF26B9-3AB5-4575-9C4B-5BD50E000F05Q37221714-85C5CB51-1C00-4E61-A6C8-718FD33F6E87Q37511451-E1F0DABD-27E8-46B6-8428-B83431620C55Q37554135-56E0D16C-1A7F-41EE-89FA-9A0DA94DFC02Q37773298-F31D38B3-3C05-413A-B67C-F3F71CA6702FQ44221740-082B892A-8969-4E3B-9FDC-81918957EEF4Q45124959-016ACB87-62C8-457D-A04F-C21A713E039AQ47739255-D432D124-CF6B-4E75-A93B-CF81D3877E9EQ50991984-F6BC2626-9C34-48B9-B7E1-FE1D85D4D488Q51666324-1E0B9494-4B7F-4FF0-98D4-9FBF781836A0
P2860
Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@en
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@nl
type
label
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@en
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@nl
prefLabel
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@en
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@nl
P2093
P1476
Interplay of cytokines and adj ...... and systemic HIV-specific CTL.
@en
P2093
Belyakov IM
Berzofsky JA
Clements JD
P304
P356
10.4049/JIMMUNOL.165.11.6454
P407
P577
2000-12-01T00:00:00Z